Title |
High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer
|
---|---|
Published in |
Cochrane database of systematic reviews, October 2014
|
DOI | 10.1002/14651858.cd007563.pub3 |
Pubmed ID | |
Authors |
Ruifeng Liu, XiaoHu Wang, JinHui Tian, KeHu Yang, Jun Wang, Lei Jiang, Xiang Yong Hao |
Abstract |
This is an updated version of the original Cochrane review published in 2010 (Issue 7).Carcinoma of the uterine cervix is the second most common cancer and the third leading cause of cancer death among women. Radiotherapy has been used successfully to treat cervical cancer for nearly a century. The combination of external beam radiotherapy (EBRT) and intracavity brachytherapy (ICBT) has become a standard treatment for cervical cancer. Whether high dose rate (HDR) or low dose rate (LDR) brachytherapy improves outcomes in terms of local control rates, survival and complications for women with cervical cancer remains controversial. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 25% |
United States | 1 | 25% |
Unknown | 2 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 50% |
Practitioners (doctors, other healthcare professionals) | 2 | 50% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 158 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 21 | 13% |
Student > Ph. D. Student | 15 | 9% |
Student > Postgraduate | 14 | 9% |
Student > Bachelor | 14 | 9% |
Other | 13 | 8% |
Other | 23 | 15% |
Unknown | 58 | 37% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 63 | 40% |
Nursing and Health Professions | 12 | 8% |
Biochemistry, Genetics and Molecular Biology | 5 | 3% |
Social Sciences | 4 | 3% |
Psychology | 2 | 1% |
Other | 10 | 6% |
Unknown | 62 | 39% |